Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Veterinary Medicine

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1501100

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1501100

Foot and Mouth Disease (FMD) Vaccine

PUBLISHED:
PAGES: 93 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5600
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 16800

Add to Cart

Description

Table of Contents

Global Foot and Mouth Disease (FMD) Vaccine Market to Reach $5.6 Billion by 2030

The global market for Foot and Mouth Disease (FMD) Vaccine estimated at US$3.1 Billion in the year 2023, is expected to reach US$5.6 Billion by 2030, growing at a CAGR of 9% over the period 2023-2030. Conventional Vaccines, one of the segments analyzed in the report, is expected to record 7.8% CAGR and reach US$3.3 Billion by the end of the analysis period. Growth in the Emergency Vaccines segment is estimated at 10.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $803.9 Million, While China is Forecast to Grow at 13% CAGR

The Foot and Mouth Disease (FMD) Vaccine market in the U.S. is estimated at US$803.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 13% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.8% and 8% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

Introducing Our Exciting New Report Features for 2024

Full access to influencer engagement stats

Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants' privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.

Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities

Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas

Complimentary report updates for one year

Competitor coverage with global market shares of major players

Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies

Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 42 Featured) -

  • Agrovet Co
  • Beohringer Ingelheim
  • Biogenesis Bago
  • Brilliant Bio Pharma Ltd.
  • Ceva Sante Animale
  • Empresa Colombiana de Productos Veterinarios S.A. VECOL S.A.
  • FMD Center
  • Godrej Agrovet Limited
  • Indian Immunologicals Limited
  • Limor de Colombia
  • Merck Animal Health
  • Merial S. A. S.
  • Vecol SA
  • Vetal Animal Health Products
  • Veterinary Serum and Vaccine Research Institute
Show more
Product Code: MCP21845

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Foot and Mouth Disease (FMD) Vaccine - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Foot and Mouth Disease (FMD) Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Conventional Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Conventional Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Conventional Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Emergency Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Emergency Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Emergency Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Cattle by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Cattle by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Cattle by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Sheep & Goat by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Sheep & Goat by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Sheep & Goat by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Pigs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Pigs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Pigs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Other Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Other Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Foot and Mouth Disease (FMD) Vaccine Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Foot and Mouth Disease (FMD) Vaccine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
  • JAPAN
    • Foot and Mouth Disease (FMD) Vaccine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
  • CHINA
    • Foot and Mouth Disease (FMD) Vaccine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
  • EUROPE
    • Foot and Mouth Disease (FMD) Vaccine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Foot and Mouth Disease (FMD) Vaccine by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
  • FRANCE
    • Foot and Mouth Disease (FMD) Vaccine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
  • GERMANY
    • Foot and Mouth Disease (FMD) Vaccine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Foot and Mouth Disease (FMD) Vaccine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Foot and Mouth Disease (FMD) Vaccine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Foot and Mouth Disease (FMD) Vaccine by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Foot and Mouth Disease (FMD) Vaccine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
  • INDIA
    • Foot and Mouth Disease (FMD) Vaccine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Foot and Mouth Disease (FMD) Vaccine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Foot and Mouth Disease (FMD) Vaccine by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Foot and Mouth Disease (FMD) Vaccine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Foot and Mouth Disease (FMD) Vaccine by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
  • AFRICA
    • Foot and Mouth Disease (FMD) Vaccine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!